지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2019.1
- 수록면
- 1 - 2 (2page)
이용수
초록· 키워드
오류제보하기
Chronic hepatitis C (CHC) has become a curable disease with the advent of potent antiviral drug. Interferon-free regimens with direct-acting antivirals (DAAs) have not only reduced adverse drug reactions but also increased sustained virologic response (SVR) rates. The possibility of viral eradication is no longer an urgent clinical issue. Instead, the cost of DAA remains as a major barrier to the universal implementation of this magic bullet to all infected patients. Clinicians are challenged to make a decision whether their patients, especially stable ones despite long history of infection, will benefit from the antiviral therapy. This issue will be resolved with the longer follow-up studies with hard outcomes such as development of liver cancer and liver-associated mortality.
목차
등록된 정보가 없습니다.
참고문헌 (5)
참고문헌 신청
신승각 / 2019 / Durability of Sustained Virologic Response and Improvement of Fibrosis Markers after Daclatasvir and Asunaprevir Treatment in Genotype 1b Hepatitis C Virus-Infected Patients: a Real Life and Multicenter Study / Journal of Korean Medical Science 34(41):1~13
Singh S / 2018 / Magnitude and kinetics of decrease in liver stiffness after antiviral therapy in patients with chronic hepatitis C : a systematic review and meta-analysis / Clin Gastroenterol Hepatol 16(1):27~38.e4
Kardashian A / 2019 / Post-sustained virologic response liver stiffness may underestimate fibrosis after direct acting antiviral-containing therapy / Clin Infect Dis 68(10):1784~1787
Lens S / 2017 / Effects of all-oral anti-viral therapy on HVPG and systemic hemodynamics in patients with hepatitis C virus-associated cirrhosis / Gastroenterology 153(5):1273~1283.e1
Mandorfer M / 2019 / Changes in HVPG predict hepatic decompensation in patients who achieved SVR to IFN-free therapy / Hepatology
Singh S / 2018 / Magnitude and kinetics of decrease in liver stiffness after antiviral therapy in patients with chronic hepatitis C : a systematic review and meta-analysis / Clin Gastroenterol Hepatol 16(1):27~38.e4
Kardashian A / 2019 / Post-sustained virologic response liver stiffness may underestimate fibrosis after direct acting antiviral-containing therapy / Clin Infect Dis 68(10):1784~1787
Lens S / 2017 / Effects of all-oral anti-viral therapy on HVPG and systemic hemodynamics in patients with hepatitis C virus-associated cirrhosis / Gastroenterology 153(5):1273~1283.e1
Mandorfer M / 2019 / Changes in HVPG predict hepatic decompensation in patients who achieved SVR to IFN-free therapy / Hepatology
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Drug-drug interactions with direct-acting antivirals ? less is more
Clinical and Molecular Hepatology
2021 .01
-
Hepatitis C Virus and Antiviral Drug Resistance
Gut and Liver
2016 .01
-
Real-world Effectiveness and Safety of Direct-acting Antiviral Agents in Patients with Chronic Hepatitis C Genotype 2 Infection: Korean Multicenter Study
Journal of Korean Medical Science
2021 .01
-
Estimation of Direct Medical Costs Related to Chronic Hepatitis C: A Rationale for Early Antiviral Therapy
Gut and Liver
2017 .01
-
Predictive Value of Antiviral Effects in the Development of Hepatocellular Carcinoma in the General Korean Population with Chronic Hepatitis B
Gut and Liver
2016 .01
-
Direct-Acting Antiviral Therapy and Risk of Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C
Gut and Liver
2021 .01
-
Therapy with Direct-Acting Antiviral Agents for Hepatitis C-Related Liver Cirrhosis
Gut and Liver
2017 .01
-
More evidence that direct acting antiviral therapy is safe and effective in cirrhosis and chronic kidney disease including peritoneal dialysis
Clinical and Molecular Hepatology
2020 .01
-
Use of direct antiviral agents in liver transplant recipients with hepatitis C virus in Korea : 2-center experience
Annals of Surgical Treatment and Research
2018 .09
-
Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea
Clinical and Molecular Hepatology
2015 .01
-
Final Report of Unmet Needs of Interferon-Based Therapy for Chronic Hepatitis C in Korea: Basis for Moving into the Direct-Acting Antiviral Era
Gut and Liver
2017 .07
-
Immunotherapy for Chronic Hepatitis B Virus Infection
Gut and Liver
2018 .01
-
Recent update of the 2017 Korean Association for the Study of the Liver (KASL) treatment guidelines of chronic hepatitis C: Comparison of guidelines from other continents, 2017 AASLD/IDSA and 2016 EASL
Clinical and Molecular Hepatology
2018 .01
-
HCV, Interferon Therapy Response, Direct Acting Antiviral Therapy Revolution and Pakistan: Future Perspectives
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Barriers to treatment of failed or interferon ineligible patients in the era of DAA: single center study
Clinical and Molecular Hepatology
2017 .01
-
Effect of rapid influenza diagnostic tests on patient management in an emergency department
Clinical and Experimental Emergency Medicine
2019 .01
-
Healthcare Costs for Chronic Hepatitis C in South Korea from 2009 to 2013: An Analysis of the National Health Insurance Claims’ Data
Gut and Liver
2017 .01
-
Low-level viremia in patients undergoing antiviral therapy: Does it indicate time for a change?
Clinical and Molecular Hepatology
2020 .01
-
천연물 유래의 반려동물 항바이러스활성물질 연구 동향
생약학회지(Korean Journal of Pharmacognosy)
2019 .03
-
Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy
Clinical and Molecular Hepatology
2020 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0